A股药概念股拉升，塞力医疗触及涨停，荣昌生物涨超7%，舒泰神涨超6%，昭衍新药、翰宇药业纷纷上扬。消息面上，国家医保局、国家卫生健康委印发《支持创新药高质量发展的若干措施》，其中提出，支持医保数据用于创新药研发。

Core Viewpoint - The A-share pharmaceutical sector experienced a significant rally, with notable stocks such as Saily Medical hitting the daily limit, Rongchang Bio rising over 7%, and Shutai Shen increasing by more than 6% due to supportive government measures for innovative drug development [1] Group 1 - The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs [1] - The new measures include the use of medical insurance data to facilitate the research and development of innovative drugs [1]